Published in Br J Haematol on July 01, 1970
The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest (1977) 1.58
Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol (1995) 1.57
The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest (1974) 1.54
Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response. J Exp Med (1976) 1.48
Platelet interaction with polymerizing fibrin. J Clin Invest (1972) 1.31
Platelet interaction with bacteria. 3. Ultrastructure. Am J Pathol (1973) 1.25
Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. Immunology (1977) 1.25
Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion. J Clin Invest (1977) 1.20
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest (1989) 1.20
Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid. EMBO J (1998) 1.09
Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol (1989) 1.06
Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans. Clin Exp Immunol (1987) 1.02
The novel inositol lipid phosphatidylinositol 3,4-bisphosphate is produced by human blood platelets upon thrombin stimulation. Biochem J (1990) 1.00
Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol (1990) 0.98
Arachidonate mobilization in diacyl, alkylacyl and alkenylacyl phospholipids on stimulation of rat platelets by thrombin and the Ca2+ ionophore A23187. Biochem J (1986) 0.97
Binding of collagen alpha1 chains to human platelets. J Clin Invest (1977) 0.96
Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis. J Clin Invest (1973) 0.95
Immunological identification of the major platelet low-Km cAMP phosphodiesterase: probable target for anti-thrombotic agents. Proc Natl Acad Sci U S A (1986) 0.95
Arachidonyl transfer from diacyl phosphatidylcholine to ether phospholipids in rat platelets. Biochem J (1984) 0.92
The role of glandular kallikrein in the formation of a salivary proline-rich protein A by cleavage of a single bond in salivary protein C. Biochem J (1983) 0.91
Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets. Biochem J (1993) 0.90
Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin. Br J Pharmacol (1991) 0.89
Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall. J Clin Invest (1979) 0.89
Activation of phospholipase C associated with isolated rabbit platelet membranes by guanosine 5'-[gamma-thio]triphosphate and by thrombin in the presence of GTP. Biochem J (1987) 0.87
Complement-dependent platelet injury by staphylococcal protein A. J Exp Med (1972) 0.87
Activation of stimulus-specific serine esterases (proteases) in the initiation of platelet secretion. I. Demonstration with organophosphorus inhibitors. J Exp Med (1976) 0.87
Absence of an anaphylactic vasopermeability mechanism for immune complex deposition in the Heymann nephritis of rats. Clin Exp Immunol (1980) 0.87
Subcellular localization of inositol lipids in blood platelets as deduced from the use of labelled precursors. Biochem J (1987) 0.86
Interaction of Ca2+ and protein phosphorylation in the rabbit platelet release reaction. J Clin Invest (1980) 0.85
Release of a slow-reacting substance from rabbit platelets. J Clin Invest (1981) 0.84
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes. Immunology (1983) 0.83
Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. Br J Pharmacol (1987) 0.82
Arachidonate cannot be released directly from diacyl-sn-glycero-3-phosphocholine in thrombin-stimulated platelets. Biochem J (1989) 0.81
Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor. Br J Pharmacol (1992) 0.81
Thrombin-induced inositol trisphosphate production by rabbit platelets is inhibited by ethanol. Biochem J (1988) 0.81
Transfer of adenine nucleotides between the releasable and nonreleasable compartments of rabbit blood platelets. J Cell Biol (1975) 0.81
Platelet accumulation and turnover on de-endothelialized aortae in rats. Br J Exp Pathol (1989) 0.81
Platelet release reaction and aggregation induced by canatoxin, a convulsant protein: evidence for the involvement of the platelet lipoxygenase pathway. Br J Pharmacol (1985) 0.80
Autosensitization and immune complexes in chronic idiopathic thrombocytopenic purpura. Clin Exp Immunol (1980) 0.80
Continued platelet interaction with de-endothelialized aortae associated with slower re-endothelialization and more extensive intimal hyperplasia in spontaneously diabetic BB Wistar rats. Int J Exp Pathol (1993) 0.78
Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid. J Clin Invest (1983) 0.78
Blood cells: an historical account of the roles of purinergic signalling. Purinergic Signal (2015) 0.78
Aggregation-related association of lipid with the cytoskeleton of rabbit and human platelets prelabeled with [3H]palmitic acid. Similar effects of adenosine diphosphate- and thrombin-induced aggregation. J Clin Invest (1988) 0.77
Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung. Br J Pharmacol (1993) 0.77
The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. Biochem J (1987) 0.77
Platelet aggregation in platelet suspensions from Mongolian gerbils (Meriones unguiculatus). Can J Comp Med (1983) 0.77
Protein kinase C promotes arachidonate mobilization through enhancement of CoA-independent transacylase activity in platelets. Biochem J (1991) 0.76
Influence of plasma protein content and platelet number on the potency of PAF and its antagonist RP 59227 in rabbit platelet preparations. Br J Pharmacol (1990) 0.75
Effect of dazoxiben on platelet-vessel wall interaction. Br J Clin Pharmacol (1983) 0.75
Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev (1970) 4.48
Preparation of suspensions of washed platelets from humans. Br J Haematol (1972) 4.02
Platelet aggregation and release of ADP, serotonin and histamine associated with phagocytosis of antigen-antibody complexes. Proc Soc Exp Biol Med (1965) 2.91
Phyllosilicates on Mars and implications for early martian climate. Nature (2005) 2.66
The effect of acetylsalicyclic acid on platelet function. J Exp Med (1968) 2.35
Platelet phagocytosis and aggregation. J Cell Biol (1965) 2.27
Response of platelets to tissue injury. Biochem Pharmacol (1968) 2.01
Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine. Am J Pathol (1967) 1.91
Release of permeability factors from the blood platelet. Proc Soc Exp Biol Med (1966) 1.86
Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol (1975) 1.70
Fibrinogen and ADP-induced platelet aggregation. Blood (1978) 1.70
Deposition of formed elements of blood on the intima and signs of intimal injury in the aorta of rabbit, pig, and man. Lab Invest (1972) 1.63
Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits. Am J Pathol (1970) 1.60
Influence of catecholamines on nucleotide-induced platelet aggregation. Nature (1966) 1.57
Alteration of the response of platelets to surface stimuli by pyrazole compounds. J Exp Med (1967) 1.48
Enzymatic basis for platelet aggregation and release: the significance of the 'platelet atmosphere' and the relationship between platelet function and blood coagulation. Br J Haematol (1974) 1.46
Thromboembolism: a manifestation of the response of blood to injury. Circulation (1970) 1.45
Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Lab Invest (1979) 1.44
Platelet-surface interactions: relationship to thrombosis and hemostasis. Fed Proc (1967) 1.42
Platelets, thrombosis and drugs. Drugs (1975) 1.40
Effect of ADP-induced shape change on incorporation of 32P into platelet phosphatidic acid and mono-, di- and triphosphatidyl inositol. Br J Haematol (1973) 1.38
Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. J Lab Clin Med (1977) 1.35
Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest (1967) 1.33
Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin. Blood (1979) 1.31
Platelet interaction with polymerizing fibrin. J Clin Invest (1972) 1.31
Changes in 32 p-labelling of platelet phospholipids in response to ADP. Br J Haematol (1972) 1.29
Release of 14C-serotonin during initial platelet changes induced by thrombin, collagen, or A23187. Blood (1977) 1.29
In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemost (1976) 1.22
Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival. Lab Invest (1982) 1.22
Changes in 32P-content of phosphatidic acid and the phosphoinositides of rabbit platelets during aggregation induced by collagen or thrombin. Br J Haematol (1974) 1.20
The effect of platelet age on platelet adherence to collagen. J Clin Invest (1968) 1.20
Platelet economy (platelet survival and turnover). Br J Haematol (1966) 1.20
Rôle of platelets in thrombosis. Thromb Diath Haemorrh Suppl (1966) 1.19
Platelet aggregation and release: effects of low concentrations of thrombin or collagen. Am J Physiol (1973) 1.18
Modification of platelet function. Ann N Y Acad Sci (1972) 1.18
The effect of plasma proteins on the interaction of platelets with glass surfaces. J Lab Clin Med (1969) 1.16
Clq inhibition of the interaction of collagen with human platelets. J Immunol (1976) 1.16
Localized protein accumulation in the wall of the aorta. Exp Mol Pathol (1967) 1.15
The platelet cytoskeleton stabilizes the interaction between alphaIIbbeta3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem (1996) 1.13
Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest (1975) 1.12
Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med (1973) 1.12
Influence of apyrase on stability of suspensions of washed rabbit platelets. Proc Soc Exp Biol Med (1971) 1.12
Experimental hemostasis in normal dogs and dogs with congenital disorders of blood coagulation. Blood (1967) 1.11
The role of blood and platelets in atherosclerosis and the complications of atherosclerosis. Thromb Diath Haemorrh (1975) 1.09
Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis. Br J Haematol (1974) 1.08
Effects of penicillin G on platelet aggregation, release, and adherence to collagen. Proc Soc Exp Biol Med (1973) 1.07
Properties of washed human platelets. Thromb Haemost (1977) 1.07
Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost (2006) 1.06
Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haematol (1973) 1.06
Isolation of human platelets from plasma by centrifugation and washing. Methods Enzymol (1989) 1.06
The role of PMN-leucocyte lysosomes in tissue injury, inflammation and hypersensitivity. VI. The participation of the PMN-leucocyte and the blood platelet in systemic aggregate anaphylaxis. Immunology (1968) 1.06
Accumulation of the inositol phosphates in thrombin-stimulated, washed rabbit platelets in the presence of lithium. Biochem J (1984) 1.06
Platelet interaction with damaged rabbit aorta. Lab Invest (1979) 1.05
Clinical pharmacology of platelets. Blood (1977) 1.04
Vessel injury, platelet adherence, and platelet survival. Arteriosclerosis (1984) 1.04
Changes in phosphatidylinositol-4,5-bisphosphate 10 seconds after stimulation of washed rabbit platelets with ADP. Blood (1982) 1.03
Platelet adherence to fibrin and collagen. J Lab Clin Med (1968) 1.03
Interactions of polylysine with platelets. Blood (1971) 1.03
Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Thromb Haemost (1983) 1.03
Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis (1992) 1.01
Platelets and diabetes mellitus. N Engl J Med (1984) 1.00
Platelets, thrombosis and atherosclerosis. Prog Biochem Pharmacol (1977) 1.00
Development of nonthrombogenicity of injured rabbit aortas despite inhibition of platelet adherence. Arteriosclerosis (1986) 1.00
Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science (1976) 0.99
Inhibition and reversal of platelet aggregation by methyl xanthines. Thromb Diath Haemorrh (1967) 0.99